Search results
Showing 4216 to 4230 of 9102 results
Page 1 of 19 Taking a medicine to reduce the chance of developing breast cancer Decision aid for postmenopausal women at high risk Published
Should I stop my benzodiazepine or z-drug? This decision aid can help if you have been prescribed a benzodiazepine or z-drug for anxiety or sleeping...
Decision aid for Dementia: assessment, management and support for people living with dementia and their carers c NICE 2018. All rights reserved....
Asthma. Patient decision aid on asthma inhalers and climate change (BTS, NICE, SIGN)
Asthma inhalers and climate change What is this decision aid about? Inhalers are a key part of treating your asthma. The most important thing is that...
Cardiovascular disease. Patient decision aid on should I take a statin?
Should I take a statin? This decision aid can help you if you are thinking about taking a statin. It is for people who do not already have heart...
1 Stroke: decompressive hemicraniectomy surgery in people under 60 Patient decision aid What are the pros and cons of decompressive hemicraniectomy?...
Dementia. Patient decision aid on enteral (tube) feeding for people living with severe dementia
Decision aid for Dementia: assessment, management and support for people living with dementia and their carers c NICE 2018. All rights reserved....
Urinary tract infection (lower). Patient decision aid on cystitis: taking an antibiotic
Cystitis: taking an antibiotic Information to help women who are not pregnant discuss the options with their healthcare professionals. Published...
Frequently Asked Questions ↓ Proton pump inhibitor medication (PPI) Laparoscopic surgery (also known as keyhole surgery) Why would I be offered this...
The EQ-5D is a short questionnaire used to understand how a person’s health affects their quality of life. It is used in health research and to help inform decisions about healthcare treatments.
NICE has implemented new measures to evaluate the cost-effectiveness of medicines, following a policy change that aims to give patients improved access to treatments. This follows the government’s decision to increase the thresholds that NICE can use in technology appraisals to £25,000 to £35,000 per quality-adjusted life year gained.
Find out more about changes to NICE’s cost-effectiveness thresholds and the recent EQ-5D-5L public consultation.
Home What NICE does Our guidance Modular updates {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem"
Over the next year, our prioritisation decisions will be shaped by the government’s strategic direction for health and life sciences, and by the needs of the NHS, local systems and the people who use services.
Our centralised approach to prioritising our guidance topics ensures that we produce guidance that's relevant, timely, accessible, and has demonstrable impact.